ClinicalTrials.gg
Drug

Aprotinin clinical trials

studies test it
10
open now
1
in phase 3
5
first study started
2003

How each study uses Aprotinin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Aprotinin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
29 Dec 1993 · TRASYLOL · BLA 020304 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Aprotinin
4
Trasylol (Aprotinin, BAYA0128)
4

Studies by the year they started

10 studies that test it; most in 2005 (4)

Studies that test Aprotinin, by start year
YearStudies
20031
20041
20054
20062
20201
20261

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 3
5
Phase 4
1
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 6 · Other 4

Bayer (4) · Imperial College London (1) · Nycomed (1) · Nemours Children's Clinic (1) · Fundacion del Hospital Nacional de Paraplejicos para la Investigacion y la Integracion (1) · Dartmouth-Hitchcock Medical Center (1) · Aviron LLC (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses Aprotinin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 10

Codes

What other systems call Aprotinin · ClinicalTrials.gg INT007703

  • MeSH (NLM) D007611AprotininConfirmed ClinicalTrials.gov, Wikidata
  • UNII (FDA) 04XPW8C0FLAPROTININConfirmed FDA, Wikidata
  • RxNorm 1056Confirmed FDA, Wikidata
  • Wikidata Q418625aprotininConfirmed FDA, Wikidata
  • NCI Thesaurus C47402AprotininOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.